webinar softgroup gs1 healthcare dovema

[Webinar]: “Case study of Dovema: a success story of proactive thinking” by GS1 and SoftGroup


Learn more about the benefits of GS1 Standards, serialization and aggregation




Discover how the pharma CMO Dovema has answered the track and trace requirements in European and Russian markets thanks to GS1 Standards.

We are pleased to invite you to an online training seminar where you have an opportunity to learn about successful GS1 standards implementation.


Date:  20 May 2021 | 2:00 P.M (CET) 


Working language: English



Key topics


  • Serialization and aggregation requirements in European  and Russian markets in accordance with GS1 standards
  • Project specifications
  • Certified Solution following GS1 standards and EU&RU authorities’ requirements





GS1 Bulgaria

GS1 is an international not-for-profit association with Member Organisations in over 112 countries. GS1 is dedicated to the design and implementation of global standards and solutions to improve the efficiency and visibility of supply and demand chains globally and across sectors. The GS1 system of standards is the most widely used supply chain standards system in the world.



SoftGroup is a software company that provides all-in-one traceability technology to the pharmaceutical industry worldwide. In our 17 years of experience, we are recognized as a reliable serialization and aggregation solution provider from Big Pharma Leaders with many production lines to small Marketing Authorization Holders (MAHs) with no real production.



Go to Webinar`s Recording


The video is available on-demand HERE





Serialization requirements, aggregation requirements, GS1 standards


By continuing to use the site, you agree to the terms of our Privacy and Cookies Policy and the use of cookies. Privacy and Cookies Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.